This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (22)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Case Report

JAMES H. GETZEN, MD; WAYNE SPEIGGLE, MD

Arch Intern Med. 1963;112(2):168-170.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The potential antigenicity of clinical dextran is well documented.^1-9 Observed side reactions following intravenous infusion include: headache, chills, flushing, urticaria, angioneurotic edema, wheezing, abdominal pain, nausea, chest pain, vasomotor rhinitis, delayed pain in the joints, swelling of the extremities, hypotension, and syncope.⁵

Dextran is generally considered as the emergency plasma expander of choice in the treatment of hypovolemic shock during a period when whole blood is not available. Bernstein and Evans ⁹ suggested the use of dextran to protect patients who are to undergo various angiographic procedures.

The purpose of presenting this case is to point out that dextran is a potentially dangerous material, capable of producing a serious reaction. This case report is of a middle-aged, postoperative patient who received dextran infusion resulting in anaphylaxis, purpuric manifestations leading to myocardial damage, and terminal uremia.

Report of Case

This 53-year-old white male was admitted to Charleston Memorial Hospital . . . [Full Text PDF of this Article]

Author Affiliations
CHARLESTON, W VA

Department of Medicine, Memorial Hospital.

Footnotes
Received for publication Sept 10, 1962; accepted Feb 12, 1963.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?